Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus

Authors:
  • PKPieter J. Kostense
    Pieter J. Kostense
  • PEPetra E. D. Eysink
    Petra E. D. Eysink
  • BPBettine C. P. Polak
    Bettine C. P. Polak
  • PBPieter J. Beks
    Pieter J. Beks
  • CJCornelis Jakobs
    Cornelis Jakobs
  • JDJacqueline M. Dekker
    Jacqueline M. Dekker
  • GNGiel Nijpels
    Giel Nijpels
  • RHRobert J. Heine
    Robert J. Heine
  • CSCoen D. A. Stehouwer
    Coen D. A. Stehouwer

Abstract
DIABETIC retinopathy is the leading cause of blindness among patients with type 2 diabetes mellitus (DM).1,2 About one third of all cases of impaired visual function in patients with type 2 DM is attributable to retinopathy, the remainder to cataract, glaucoma, macular degeneration, and other causes. Blindness has been estimated to be 25 times more common in persons with DM than in those without DM.3 After 20 years of having DM, more than 60% of the patients with type 2 DM have some degree of retinopathy.2 The pathogenetic mechanisms of diabetic retinopathy are incompletely understood.